Clinical Trials Directory

Trials / Unknown

UnknownNCT05448222

Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies

Effect of Sarcopenia on the Efficacy and Prognosis of HCC Treated With Systemic Therapies

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
First Affiliated Hospital of Wenzhou Medical University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Sarcopenia is associated with the prognosis of HCC and cholangiocarcinoma. But there has been rare study focusing on the effect of sarcopenia on the prognosis of HCC treated with systemic therapy, such as interventional therapy, targeted therapy, chemotherapy and immunotherapy and so on.

Detailed description

By tracking the short-term and long-term results of HCC patients treated with systemic therapy,the difference of short-term results between patients with sarcopenia and patients without sarcopenia was analyzed, and the correlation between sarcopenia and short-term and long-term results of patients after systemic treatments was explored, so as to improve people's awareness of sarcopenia and pay attention to its prevention and treatment.All implementation details are based on the newest EuropeanWorking Group on Sarcopenia in Older People(EWGSOP) definition. The investigators consecutively admitted patients the questionnaire and evaluated the assessment of muscle strength (grip strength test and chair stand test), muscle quantity (L3 plane total skeletal muscle area) and physical performance (gait test) following the F-A-C-S approach, to confirm patients with sarcopenia accurately. And by tracking the short-term and long-term outcomes, the differences were analyzed and the relationship between sarcopenia and prognosis of systemic treatments was explored.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTDiagnostic Test: gait speed; ct scan; grip strength and chair stand testThe chair stand test was administered, and the time required for the patient to stand five times from a sitting position without using the arms was measured. CT scan was to scan the patient's third lumbar level. For the gait speed test, the time that patients spent walking 8 meters on a flat indoor floor at usual walking speed was measured.Grip strength test:the dominant hand and the nondominant hand were measured twice intermittently (kg), and the average value of 4 values was obtained.

Timeline

Start date
2022-07-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2022-07-07
Last updated
2023-09-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05448222. Inclusion in this directory is not an endorsement.